颈动脉狭窄支架置入术费用驱动因素研究
基于Vizient全国医院数据库166家医院7369例颈动脉支架置入术住院病例,分析费用相关因素。结果显示平均费用12834.14美元,重症监护入住频率低的机构费用更低,症状性狭窄和肥胖与费用增加相关。
要点
- 重症监护入住频率低的机构费用更低,且卒中发生率与30天再入院率无差异
- 症状性狭窄患者费用高于无症状性狭窄患者
- 肥胖与颈动脉支架置入术住院费用增加相关
核心结论
- 重症监护入住、症状性狭窄和肥胖与颈动脉支架置入术费用增加相关,这些数据有助于识别改善该手术成本效益的机会。
研究设计与样本
- 使用Vizient全国医院报告结局数据库,通过手术MS-DRG及相关ICD-9和ICD-10代码识别因无症状或症状性颈动脉狭窄行颈动脉支架置入术的患者,共166家医院报告7369例住院病例。
主要发现
- 所有报告机构的平均每次住院费用为12834.14美元(SEM,492.88)。
- 重症监护入住频率处于最低25百分位的机构住院费用低于高于75百分位的机构(10971.30美元[SEM,460.67] vs 14992.90美元[964.29];P = .002),住院期间卒中发生率(2.2%[SEM,0.3] vs 2.0%[0.4];P = .877)和30天再入院率(1.9%[SEM,0.4] vs 2.5%[SEM,0.6];P = .329)无差异。
- 症状性狭窄患者住院费用高于无症状性狭窄患者(20462.10美元[SEM,819.93] vs 11285.20美元[SEM,347.11];P < .001)。
- 肥胖与更高的住院费用相关(14176.20美元[SEM,597.13] vs 12287.10美元[SEM,395.73];P < .001)。
临床怎么用
- 可关注重症监护入住频率较低的机构模式,在不增加卒中或再入院风险的前提下优化颈动脉支架置入术费用。
- 对症状性狭窄和肥胖患者,可针对性评估资源使用以改善成本效益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to identify factors associated with cost of carotid artery stenting (CAS). METHODS: Patient and hospital characteristics affecting cost of admission for CAS were identified using the Vizient national database of hospital-reported outcomes. Patients who underwent CAS for either asymptomatic or symptomatic carotid stenosis were identified using surgical Medicare Severity-Diagnosis Related Groups and appropriate International Classification of Diseases, Ninth Revision and Tenth Revision codes. RESULTS: There were 166 hospitals that reported outcomes from 7369 inpatient admissions for CAS. Each institution reported a mean value for cost related to patient care per admission for CAS; the average cost across all reporting institutions was $12,834.14 (standard error of the mean [SEM], 492.88). Institutions in the lowest 25th percentile with respect to frequency of intensive care unit admission after CAS had lower cost of admission than institutions above the 75th percentile ($10,971.30 [SEM, 460.67] vs $14,992.90 [964.29]; P = .002), without any differences in incidence of stroke during admission (2.2% [SEM, 0.3] vs 2.0% [0.4]; P = .877) or 30-day readmission (1.9% [SEM, 0.4] vs 2.5 [0.6]; P = .329). Admissions for patients with symptomatic stenosis were more expensive than those with asymptomatic stenosis ($20,462.10 [SEM, 819.93] vs $11,285.20 [347.11]; P < .001). Obesity was also associated with greater costs of admission ($14,176.20 [SEM, 597.13] vs $12,287.10 [395.73]; P < .001). CONCLUSIONS: Admission to an intensive care unit, symptomatic stenosis, and obesity were associated with increased costs in patients undergoing CAS. These data may aid in identifying opportunities to improve the cost-effectiveness of this procedure.
引用
- Rinaldo L, Brinjikji W, Cloft H, et al. Investigation into drivers of cost of stenting for carotid stenosis. J Vasc Surg. 2017. PMID: 28559178. doi:10.1016/j.jvs.2017.03.433
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。